Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy

213

Citations

45

References

2007

Year

Clare Taylor, Dawn L. Hershman, Nina Shah, Nicole Suciu‐Foca, Dan P. Petrylak, Robert N. Taub, Linda T. Vahdat, Bin Cheng, Mark D. Pegram, Keith L. Knutson,

Clinical Cancer Research

Abstract

Humoral immune sensitization occurs during treatment with chemotherapy and trastuzumab. Further studies are warranted to investigate whether augmented anti-HER-2/neu humoral and cellular immunity contributes mechanistically to clinical outcome.

References

	Year	Citations

Page 1